×
About 10,628 results

ALLMedicine™ Viral Hepatitis Center

Research & Reviews  4,957 results

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should ...
https://doi.org/10.2217/imt-2020-0273
Immunotherapy De Keukeleire SJ, Vermassen T et. al.

Jan 25th, 2021 - More patients with chronic hepatitis B and C infection are being exposed to immune checkpoint inhibitors (ICIs), but the safety and efficacy of ICIs in patients with chronic viral hepatitis are still poorly described. To explore this interaction, ...

Model systems for studying extrahepatic pathogenesis of hepatitis E virus. Current know...
https://doi.org/10.1002/rmv.2218
Reviews in Medical Virology; El-Mokhtar MA, Sayed IM

Jan 21st, 2021 - Hepatitis E Virus is the most common cause of acute viral hepatitis globally. HEV infection is endemic in developing countries. Also, autochthonous and sporadic cases are reported in developed countries. HEV causes acute and chronic infections. Be...

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785379
Canadian Journal of Gastroenterology & Hepatology; Cojocariu C, Singeap AM et. al.

Jan 18th, 2021 - Nonalcoholic fatty liver disease has become the main concern of hepatologists around the world and the main research topic for identifying effective and safe therapy. Advances in the treatment of chronic viral hepatitis in recent years have opened...

Trend of the mortality of major liver diseases and its impact on life expectancy in Chi...
https://doi.org/10.1093/pubmed/fdaa261
Journal of Public Health (Oxford, England); Zhu J, Wang P et. al.

Jan 17th, 2021 - Liver diseases are the serious cause of death in China. We aim to describe the trends and disparities of major liver disease mortality rates and the loss of life expectancy (LLE) in China. Annual percentage change (APC) and average APC (AAPC) were...

Hepatitis E should be a global public health priority: recommendations for improving su...
https://doi.org/10.1080/14760584.2020.1874930
Expert Review of Vaccines; Kirkwood CD, Dobscha KR et. al.

Jan 14th, 2021 - Hepatitis E virus (HEV) is an important cause of enterically transmitted viral hepatitis and a significant contributor to maternal mortality in endemic regions around the world, yet the global response to date has been limited. HEV is a disease of...

see more →

Guidelines  13 results

HIV and Viral Hepatitis - CDC
https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viral-hepatitis.pdf

Jun 26th, 2019 - People with HIV infection are affected disproportionally by viral hepatitis. Nearly 75% of people with HIV who report a history of injection drug use also are infected with hepatitis C virus (HCV).

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2017&issue=01000&article=00013&type=Fulltext
The American Journal of Gastroenterology; Kwo,P.,et al

Jun 30th, 2017 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Joint Society statement for elimination of viral hepatitis.
https://doi.org/10.5604/16652681.1226808
Annals of Hepatology; Brahm J, Castera L et. al.

Jan 4th, 2017 - Joint Society statement for elimination of viral hepatitis.|2017|Brahm J,Castera L,Hou J,Lindor K,|standards,diagnosis,mortality,prevention & control,virology,standards,standards,standards,

2015 Sexually Transmitted Diseases Treatment Guidelines- Viral Hepatitis
https://www.cdc.gov/std/tg2015/hepatitis.htm

Jun 4th, 2015 - Hepatitis A, caused by infection with the hepatitis A virus (HAV), has an incubation period of approximately 28 days (range: 15–50 days) (819). HAV replicates in the liver and is shed in high concentrations in feces from 2–3 weeks before to 1 week.

Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted...
https://www.ncbi.nlm.nih.gov/pubmed/23135062
MMWR. Recommendations and Reports : Morbidity and Mortali...

Nov 8th, 2012 - This report summarizes current (as of 2011) guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral h...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  5,265 results

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should ...
https://doi.org/10.2217/imt-2020-0273
Immunotherapy De Keukeleire SJ, Vermassen T et. al.

Jan 25th, 2021 - More patients with chronic hepatitis B and C infection are being exposed to immune checkpoint inhibitors (ICIs), but the safety and efficacy of ICIs in patients with chronic viral hepatitis are still poorly described. To explore this interaction, ...

Model systems for studying extrahepatic pathogenesis of hepatitis E virus. Current know...
https://doi.org/10.1002/rmv.2218
Reviews in Medical Virology; El-Mokhtar MA, Sayed IM

Jan 21st, 2021 - Hepatitis E Virus is the most common cause of acute viral hepatitis globally. HEV infection is endemic in developing countries. Also, autochthonous and sporadic cases are reported in developed countries. HEV causes acute and chronic infections. Be...

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785379
Canadian Journal of Gastroenterology & Hepatology; Cojocariu C, Singeap AM et. al.

Jan 18th, 2021 - Nonalcoholic fatty liver disease has become the main concern of hepatologists around the world and the main research topic for identifying effective and safe therapy. Advances in the treatment of chronic viral hepatitis in recent years have opened...

Trend of the mortality of major liver diseases and its impact on life expectancy in Chi...
https://doi.org/10.1093/pubmed/fdaa261
Journal of Public Health (Oxford, England); Zhu J, Wang P et. al.

Jan 17th, 2021 - Liver diseases are the serious cause of death in China. We aim to describe the trends and disparities of major liver disease mortality rates and the loss of life expectancy (LLE) in China. Annual percentage change (APC) and average APC (AAPC) were...

Hepatitis E should be a global public health priority: recommendations for improving su...
https://doi.org/10.1080/14760584.2020.1874930
Expert Review of Vaccines; Kirkwood CD, Dobscha KR et. al.

Jan 14th, 2021 - Hepatitis E virus (HEV) is an important cause of enterically transmitted viral hepatitis and a significant contributor to maternal mortality in endemic regions around the world, yet the global response to date has been limited. HEV is a disease of...

see more →

News  367 results

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
https://www.medscape.com/viewarticle/944180

Jan 14th, 2021 - In an effort to counteract alarming trends in rising hepatitis infections, the U.S. Department of Health and Human Services has developed and released its Viral Hepatitis National Strategic Plan 2021-2025, which aims to eliminate viral hepatitis i...

Youth Depression Tied to a Wide Range of Illnesses, Early Death
https://www.medscape.com/viewarticle/942816

Dec 16th, 2020 - Children and adolescents with depression may be at dramatically increased risk for premature death or an array of diseases later in life, new research suggests. Youths with depression had a significantly increased risk for being diagnosed with any...

Liver Cancer Rates Are Rising; So Is Optimism Around Its Treatment
https://www.medscape.com/viewarticle/941160

Nov 19th, 2020 - In celebration of Medscape's 25th birthday, we are highlighting key breakthroughs that have defined the last quarter century of medicine, as chosen by experts in their respective fields. Over the past 25 years, cirrhosis and its related complicati...

Address Medical Mistrust to Recruit Minorities to COVID-19 Trials
https://www.staging.medscape.com/viewarticle/940021

Oct 28th, 2020 - To end HIV and control COVID-19, medicine must earn back the trust of people in Black, Latinx, and Native American communities, said Jonathan Mermin, MD, MPH, director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at...

Address Medical Mistrust to Recruit Minorities to COVID-19 Trials
https://www.medscape.com/viewarticle/940021

Oct 28th, 2020 - To end HIV and control COVID-19, medicine must earn back the trust of people in Black, Latinx, and Native American communities, said Jonathan Mermin, MD, MPH, director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at...

see more →

Patient Education  25 results see all →